Navigation Links
Cornerstone Therapeutics To Present at Deutsche Bank's 35th Annual Healthcare Conference
Date:4/27/2010

In the news release, Cornerstone Therapeutics To Present at Deutsche Bank's 35th Annual Healthcare Conference, issued 27-Apr-2010 by Cornerstone Therapeutics Inc. over PR Newswire, we are advised by the company that the first paragraph, first sentence, should indicate that the presentation time has been updated to 8:00 AM ET from 1:35 PM ET as originally issued. The complete, updated release follows:

Cornerstone Therapeutics To Present at Deutsche Bank's 35th Annual Healthcare Conference

CARY, N.C., April 27 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that Craig A. Collard, President and Chief Executive Officer, will be presenting a corporate overview at Deutsche Bank's 35th Annual Healthcare Conference at 8:00 AM ET on Wednesday, May 5, 2010, at the InterContinental Hotel in Boston, MA.

A live and archived webcast of Cornerstone's presentation will be available through the Investor Relations section of the Company's website, www.crtx.com.

About Cornerstone Therapeutics

Cornerstone Therapeutics Inc. (Nasdaq: '/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
2. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
3. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
4. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
5. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
6. Logical Therapeutics Initiates Enrollment in New Gastrointestinal Safety Study in Osteoarthritis Patients
7. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
8. United Therapeutics Corporation To Announce First Quarter 2010 Financial Results Before Market Open on Thursday, April 29, 2010
9. Orexigen(R) Therapeutics Appoints Wendy Dixon, Ph.D. to Board of Directors
10. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
11. Orexigen(R) Therapeutics and Patheon Announce Exclusive Manufacturing Agreement for Contrave(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 JenaValve Technology, Inc., a ... implantation (TAVI) systems for the treatment of aortic valve disease, ... enaValve Eval U ation of Long Term P erformance ... E vere Ao R tic Stenosis (JUPITER) Registry at EuroPCR ... registry to evaluate five-year long term safety and effectiveness of ...
(Date:5/22/2013)... and CAESAREA, Israel , May ... , New clinical data presented from the DEFLECT-I study ... Device reduces brain lesion volume during TAVR (Transcatheter Aortic ... Keystone Heart Scientific Advisory Board announces consensus on ... rising regarding the importance and need for cerebral protection ...
(Date:5/22/2013)...  The Lupus Research Institute (LRI) today is hosting ... for lupus nephritis, a serious kidney complication of lupus ... launched a new international alliance of researchers specializing in ... More than 50 of the world,s top ... focus on two critical questions: 1) Which new medicines ...
Breaking Medicine Technology:First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2
... AMSTERDAM, February 14, 2012 Application ... , , Elsevier , a ... and services, announces the launch of an expert identification ... a platform for search, analysis and research synthesis, with ...
... the digital imaging solution provider, announced today the launch ... DR solution, exclusively sold from Viztek is ideal for ... solution; the ViZion DR Straight Arm offers superior image ... software. The complete ViZion DR Rad Room ...
Cached Medicine Technology:Elsevier Introduces Expert Discovery Application for SciVerse Hub 2Elsevier Introduces Expert Discovery Application for SciVerse Hub 3Elsevier Introduces Expert Discovery Application for SciVerse Hub 4
(Date:5/22/2013)... that make energy to keep cells alive is a ... drug-resistant forms of cancer source of a serious ... a new study published in the journal ACS ... explain that doxorubicin and other common forms of chemotherapy ... cancer cells. Cancer cells divide and multiply faster than ...
(Date:5/22/2013)... Center at Hackensack University Medical Center, one of the ... cancer experts, for presentation and discussion of the latest ... in oncology, on Friday, June 7 from 7:00am to ... of the nation,s top immunology experts to review the ... both in solid and liquid tumors," said Andre Goy ...
(Date:5/22/2013)... 22, 2013 Peak Solar introduces unique, ... targeted to help potential customers make informed buying choices. ... to ensuring customer satisfaction is to give them the ... taken this advice to heart. Solar training seminars will ... implementation of different solar kits . , Poised ...
(Date:5/22/2013)... 22 (HealthDay News) -- Children and teens exposed to ... to develop cancer, according to a large, long-term study. ... group of 10,000 young people who each had one ... expected to occur within 10 years, according to researchers ... should carefully weight the risks to patients when making ...
(Date:5/22/2013)... the gene p53 turns off cancer. However, when existing drugs boost ... challenge. A study published in the journal Cell Reports ... reactivation create more of the protein p21 than the protein PUMA; ... first time, the current study shows a handful of genes that ... most commonly mutated cancer genes. Tumors turn it off and then ...
Breaking Medicine News(10 mins):Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:Online Solar Training Seminars Aimed at Informing Consumers 2Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:Study details genes that control whether tumors adapt or die when faced with p53 activating drugs 2
... -- There,s more evidence that use of the oral contraceptive ... some women experience during their period. Some previous research, ... could help women with painful periods, but a 2009 review ... such a conclusion. The new findings, from a Swedish ...
... MD Jan. 16, 2012 Listen up, pedestrians wearing ... you? Many probably can,t, especially young adult males. ... tripled in six years, according to new research from the ... Maryland Medical Center in Baltimore. In many cases, the ...
... Gordon HealthDay Reporter , TUESDAY, Jan. 17 (HealthDay News) ... American children are obese, new government reports show. That,s the ... years, those rates have remained roughly the same. "The stabilization ... this is not just the U.S. It,s happening all over the ...
... 17, 2012) Researchers at Columbia University Medical Center ... events that give rise to a type of esophageal ... the United States. The findings, published online today in ... origin and development of this deadly cancer and its ...
... the first time ever, stem cells from umbilical cords have ... lead to new treatment options for spinal cord injuries and ... "This is the first time this has been done ... Central Florida bioengineer and leader of the research group, whose ...
... HealthDay Reporter , TUESDAY, Jan. 17 (HealthDay News) ... but dissolvable, smokeless tobacco products aren,t for kids. The ... three-day U.S. Food and Drug Administration meeting this week. ... tobacco. These products are not stop-smoking aids. Instead, they are ...
Cached Medicine News:Health News:'The Pill' Can Help Ease Period Pain, Study Finds 2Health News:University of Maryland study: Headphone-distracted pedestrians face death, serious injury 2Health News:University of Maryland study: Headphone-distracted pedestrians face death, serious injury 3Health News:Americans Aren't Getting Any Skinnier 2Health News:Americans Aren't Getting Any Skinnier 3Health News:Study reveals origins of esophageal cancer 2Health News:Study reveals origins of esophageal cancer 3Health News:A first: Brain support cells from umbilical cord stem cells 2Health News:A first: Brain support cells from umbilical cord stem cells 3Health News:FDA to Weigh Safety of Tobacco Lozenges, Strips 2Health News:FDA to Weigh Safety of Tobacco Lozenges, Strips 3
... The only portable 36/70 static/kinetic/multi-color perimeter that ... room and costs only slightly more than ... perimeter,The Centerfield automatically performs static and kinetic ... to 70 with a fixation shift. Offers ...
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....
... Sun Med TruFlow™ Oxygen flowmeter with a ... warranty covering calibration and manufacturing defects. A ... meet most needs. Also available with all ... power take-off and double unit configurations. Our ...
Medicine Products: